Trending News – October 20th, 2022

Play this Episode

In this minisode, Ryan is joined by Vynamic’s Brian Schachter to discuss a few recent newsworthy items including: the Medicare reimbursement for biosimilars (00:32), 2023 Medicare Advantage Star Ratings and overall sentiment of the US Healthcare system (03:51), drug price increases outpacing inflation (10:18), and Mark Cuban’s Cost Plus Drug Company partnering with Capital Blue Cross (11:48). 


Podcast Tags: healthcare, healthcare news, life sciences, Inflation Reduction Act, biosimilars, Medicare, , drug pricing, healthcare access, Mark Cuban, Capital Blue Cross 


Source Links:  

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 



Mindy McGrath, Healthcare Industry Advisor  

[email protected] 


Ryan Hummel, Executive and Head of Provider Sector 

[email protected] 


Brian Schachter, Director 

[email protected] 

Want to learn more? Get in Touch!

Contact our team to learn more about how we can help your needs.

Let's Talk

Send us a message and we'll get back to you shortly.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.